| 书目名称 | Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models | | 编辑 | Hardeep Singh Tuli | | 视频video | | | 概述 | Explores various cellular targets for cancer therapy.Reviews the role of inflammatory molecules and reactive oxygen species as potential targets for drug development.Examines the potential of apoptoti | | 图书封面 |  | | 描述 | .This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways forthe treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.. | | 出版日期 | Book 2020 | | 关键词 | Cancer; Drug targets; Apoptosis; Cell-cycle regulators; Autophagy; Angiogenesis oxidation | | 版次 | 1 | | doi | https://doi.org/10.1007/978-981-15-7586-0 | | isbn_softcover | 978-981-15-7588-4 | | isbn_ebook | 978-981-15-7586-0 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor |
The information of publication is updating
|
|
发表于 2025-3-21 17:56:02
